Generation of a Novel Mesothelin-Targeted Oncolytic <i>Herpes</i> Virus and Implemented Strategies for Manufacturing
Background: HER2-based retargeted viruses are in advanced phases of preclinical development of breast cancer models. Mesothelin (MSLN) is a cell-surface tumor antigen expressed in different subtypes of breast and non-breast cancer. Its recent identification as a marker of some triple-negative breast...
|Main Authors:||, , , , , , , , , , , , ,|
|Series:||International Journal of Molecular Sciences|